Retour sur lavenir.net
   BEKAERT 37.900 € (+1,61 %)     BELYSSE GROUP 0.440 € (-5,78 %)     AEDIFICA 66.050 € (-0,08 %)     NYXOAH 1.380 € (+0,73 %)     MONTEA 64.500 € (+2,71 %)     VGP 71.600 € (+0,85 %)     LOTUS BAKERIES 12 140.000 € (0,00 %)     UCB 206.100 € (-1,81 %)     ASCENCIO 52.600 € (-0,19 %)     CMB.TECH 17.260 € (+1,65 %)     TUBIZE-FIN 177.400 € (-0,34 %)     VASTNED 28.000 € (-0,18 %)     COLRUYT 38.320 € (-1,29 %)     TITAN S.A. 49.420 € (+0,37 %)     UMICORE 22.000 € (+1,76 %)     CARE PROPERTY INV. 12.380 € (+1,31 %)     PROXIMUS 6.450 € (+1,10 %)     SOLVAY 25.900 € (+0,23 %)     FLUXYS BELGIUM D 21.900 € (-1,35 %)     ECONOCOM GROUP 1.525 € (+0,33 %)     BIOTALYS 1.942 € (-3,62 %)     KINEPOLIS GROUP 49.550 € (+1,12 %)     VAN DE VELDE 30.000 € (-0,33 %)     TESSENDERLO 20.900 € (-0,24 %)     CIE BOIS SAUVAGE 303.000 € (+1,34 %)     ACKERMANS V.HAAREN 273.200 € (+1,41 %)     JENSEN-GROUP 75.600 € (+0,53 %)     GIMV 46.450 € (+1,20 %)     RECTICEL 12.660 € (+0,64 %)     AGEAS 76.350 € (+1,13 %)     SOFINA 253.000 € (-0,94 %)     TINC 10.960 € (+0,74 %)     INCLUSIO SA/NV 16.150 € (-0,31 %)     MELEXIS 64.950 € (+1,48 %)     ACCENTIS 0.026 € (0,00 %)     KBC 131.950 € (+0,73 %)     RETAIL ESTATES 64.500 € (+1,26 %)     ONTEX GROUP 2.180 € (+0,69 %)     CENERGY 21.960 € (-0,27 %)     AB INBEV 69.040 € (+0,41 %)     VIOHALCO 15.440 € (-0,52 %)     EVS 27.850 € (0,00 %)     IBA 15.260 € (-1,04 %)     ORANGE BELGIUM 22.100 € (0,00 %)     SHURGARD 23.200 € (+1,75 %)     GBL 74.750 € (-0,20 %)     KBC ANCORA 94.200 € (+0,43 %)     FAGRON 22.050 € (+1,38 %)     ONWARD MEDICAL 2.800 € (+2,75 %)     WERELDHAVE BELGIUM 49.800 € (-0,20 %)     DECEUNINCK 2.525 € (+3,27 %)     SYENSQO 77.550 € (-0,06 %)     AGFA-GEVAERT 0.386 € (0,00 %)     SIPEF 108.800 € (+1,30 %)     SOLVAC NOM(RETAIL) 84.000 € (+2,44 %)     BREDERODE 105.600 € (+0,19 %)     HOME INVEST BE. 18.020 € (-0,22 %)     NYRSTAR 0.062 € (-0,32 %)     DEME GROUP 181.000 € (+0,78 %)     ARGENX SE 848.600 € (-1,19 %)  
   ABIVAX 90.450 € (-3,62 %)     EUTELSAT COMMUNIC. 1.815 € (+0,39 %)     KERING 238.000 € (+1,56 %)     METAVISIO 0.001 € (+8,33 %)     ASM INTERNATIONAL 771.600 € (+2,88 %)     VOPAK 48.140 € (+0,33 %)     TOTALENERGIES 80.030 € (-0,57 %)     GETLINK SE 18.560 € (+0,32 %)     DBT 0.069 € (-18,82 %)     STMICROELECTRONICS 42.605 € (+1,96 %)     RAPID NUTRITION 2.525 € (-6,48 %)     AKZO NOBEL 57.540 € (+0,42 %)     FORFARMERS 5.840 € (+2,46 %)     HERMES INTL 1 383.000 € (+0,58 %)     GTT 221.600 € (+2,21 %)     ABN AMRO BANK N.V. 43.370 € (+1,59 %)     MAGNUM 16.446 € (-1,52 %)     BNP PARIBAS ACT.A 102.320 € (+1,01 %)     PHILIPS KON 21.690 € (+0,51 %)     CROSSJECT 1.326 € (+1,22 %)     ASML HOLDING 1 396.200 € (+1,26 %)     AIRBUS 196.280 € (+0,76 %)     SHELL PLC 41.825 € (-2,05 %)     LVMH 410.950 € (+1,11 %)     ARTMARKET COM 3.840 € (+0,52 %)     ADYEN 914.700 € (-1,81 %)     BOLLORE 3.694 € (-0,32 %)     V LANSCHOT KEMPEN 68.050 € (+0,59 %)     SIGNIFY NV 14.640 € (-0,14 %)     AMUNDI 90.750 € (+0,39 %)     CELLECTIS 1.151 € (-14,74 %)     S.E.B. 55.400 € (-0,63 %)     JCDECAUX 24.380 € (-0,57 %)     ERAMET 43.000 € (-1,29 %)     KAUFMAN ET BROAD 21.700 € (+0,93 %)     ALSTOM 15.765 € (+0,90 %)     NRJ GROUP 6.160 € (-0,32 %)     SOCIETE GENERALE 73.670 € (+1,25 %)     SPIE 44.500 € (+1,55 %)     CSG 15.792 € (-0,79 %)     ATOS GROUP 25.540 € (+1,43 %)     THX PHARMA 3.260 € (+0,62 %)     ADP 107.200 € (-1,29 %)     EURONEXT 157.200 € (-0,44 %)     RELX 29.800 € (0,00 %)     BE SEMICONDUCTOR 178.850 € (+1,42 %)     NETGEM 1.000 € (-3,85 %)     CRCAM ATL.VEND.CCI 133.600 € (-4,00 %)     SOITEC 139.500 € (+13,41 %)     DSM FIRMENICH AG 91.780 € (+0,20 %)     SANOFI 74.350 € (+0,19 %)     PUBLICIS GROUPE SA 97.040 € (-1,78 %)     PULLUP ENTERTAIN 8.440 € (+2,18 %)     PLUXEE 15.040 € (+0,27 %)     GENSIGHT BIOLOGICS 0.111 € (-5,77 %)     VOYAGEURS DU MONDE 179.000 € (0,00 %)     RANDSTAD NV 36.800 € (-1,47 %)     DIAGNOSTIC MEDICAL 1.120 € (+1,82 %)     THERACLION 0.663 € (+3,59 %)     POUJOULAT 5.900 € (-4,53 %)  
News Réglementées
16/09/2026 18:22

EQS-Adhoc: elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment

EQS-Ad-hoc: elumeo SE / Key word(s): Capital measures / Capital increase/Capital measures / Capital increase
elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment

16-Sep-2026 / 18:22 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


 

 

Ad hoc announcement pursuant to Article 17(1) of the MAR

 

elumeo SE resolves on a capital increase against cash contributions, excluding pre-emptive rights, and a move to the Scale segment

NOT FOR PUBLICATION, DISSEMINATION OR DISTRIBUTION, WHETHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION WHERE, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH PUBLICATION, CIRCULATION OR DISTRIBUTION WOULD BE UNLAWFUL

 

Berlin, 16 September 2026 – The Board of Directors of elumeo SE (ISIN DE000A11Q059) has today decided to carry out a capital increase against cash contributions of up to 14.3 per cent of the share capital, by making partial use of the 2026 Authorised Capital, with the exclusion of shareholders’ subscription rights. To this end, up to 850,000 new no-par bearer shares (“New Shares”) with a notional value of EUR 1.00 per New Share will be issued. The placement price has been set at EUR 2.10. The New Shares will be offered to institutional investors by way of a private placement. The specific placement volume will be determined through an accelerated book-building process, which is expected to be completed by Thursday, 17 September 2026. The New Shares will carry dividend rights from 1 January 2026.

The company intends to use the newly raised equity capital to drive its organic growth. The funds are primarily to be used to strengthen working capital. In addition, the platform’s scalability for international markets is to be improved and further AI-based processes developed to deliver additional efficiency gains.

The Board of Directors also resolved today that, as a second step, the admission of elumeo SE’s shares to the Regulated Market of the Frankfurt Stock Exchange should be withdrawn and the shares should be transferred to the Scale segment of the Freiverkehr market of the Frankfurt Stock Exchange. The aim is to ensure a seamless transition of the stock market listing.

Both measures share the common aim of aligning elumeo SE’s capital market positioning with the company’s current size, structure and actual requirements.

 

Person responsible for disclosure at the issuer:

elumeo SE

Managing Director/Chief Executive Officer (CEO)

Florian Spatz

 

Contact:

elumeo SE
Investor Relations
Erkelenzdamm 59/61
10999 Berlin
Phone: +49 30 69 59 79-231
Fax: +49 30 69 59 79-650
E-Mail: ir@elumeo.com
www.elumeo.com

 

IMPORTANT NOTE:

This document and the information contained herein are for information purposes only and do not constitute a prospectus or an offer to sell, or a solicitation of an offer to purchase, securities of the Company in the United States of America (“USA”) or in any other jurisdiction. This publication must not be distributed, published or circulated in the USA, Australia, Canada or Japan. The Company’s securities may not be offered or sold in the USA without registration or an exemption from registration under the US Securities Act of 1933, as amended (the “Securities Act”). The Company’s securities have not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offering of shares in the Company.

The distribution of this notice may be restricted by law in certain jurisdictions, and any person who comes into possession of documents or other information referred to herein should familiarise themselves with such restrictions and comply with them. Failure to comply with these restrictions may constitute a breach of the securities laws of such a jurisdiction.

This notice does not constitute an offer to sell securities, nor does it constitute a solicitation of an offer to purchase securities, to persons in the United States of America, Australia, Canada, Japan or any other jurisdiction in which such an offer or solicitation would be unlawful.

 



End of Inside Information

16-Sep-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:elumeo SE
Erkelenzdamm 59/61, Portal 3b
10999 Berlin
Germany
Phone:+49 30 69 59 79-0
Fax:+49 30 69 59 79-20
E-mail:info@elumeo.com
Internet:www.elumeo.com
ISIN:DE000A11Q059
WKN:A11Q05
Listed:Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Tradegate BSX
LEI Code:391200KOQF8RGMZ3XK74
EQS News ID:2400464

 
End of AnnouncementEQS News Service

2400464  16-Sep-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière